Literature DB >> 15750154

Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values.

Chris J Jaskowiak1, Jesus A Bianco, Scott B Perlman, Jason P Fine.   

Abstract

UNLABELLED: The goal of this study was to evaluate the effect on the average standardized uptake value (avgSUV) and maximum standardized uptake value (maxSUV) of changing the number of iterations in the reconstruction process on studies acquired with PET/CT.
METHODS: Data from 50 human tumors were acquired on a PET/CT scanner, using the CT portion for attenuation correction. Reconstruction was performed using the 2-dimensional reconstruction method of ordered-subsets expectation maximization (OSEM) with 28 subsets and with 1, 2, 3, 4, 5, 10, 20, and 40 iterations. The standardized uptake value (SUV) of the studies was analyzed by positioning a region of interest tightly around the tumor and reproducing the same area on all same-study iterations for SUV measurements.
RESULTS: The differences in mean avgSUV and mean maxSUV were statistically different across different iteration groups. SUV data demonstrated that the avgSUV measurements have the most significant differences between 1 versus 2 iterations and 2 versus 3 iterations. The P values for these comparisons were less then 0.001. For maxSUV, all differences had P values less than 0.001. There also was a systematic increase in the SUVs as the number of iterations increased. The avgSUV increased at early iterations (less than 5), with just 50%-60% increasing after 5 iterations. However, maxSUV increased systematically at early iterations, and this trend continued as the number of iterations increased.
CONCLUSION: The OSEM algorithm converges sooner for avgSUV than for maxSUV. The likely reason is that avgSUV depends on low-frequency features that are recovered with fewer iterations. The differences in maxSUV were likely due to noise, which increased with the number of iterative updates, and to increased resolution and recovery of high-frequency features (i.e., tumor heterogeneity) with a larger number of iterations. Factors that determine the quantitative accuracy of iterative reconstruction may have played an additional role. Given the continued change in maxSUV with iterations, great care must be taken in selecting the number of iterative updates when using it to assess tumors and their response to chemotherapy and radiation therapy. Because 2-5 iterations with 8-28 subsets are being used in clinical settings, these data are pertinent when comparing the SUVs of a tumor before and after therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750154

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  46 in total

1.  The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.

Authors:  Bernadette G Dijkman; Olga C J Schuurbiers; Dennis Vriens; Monika Looijen-Salamon; Johan Bussink; Johanna N H Timmer-Bonte; Miranda M Snoeren; Wim J G Oyen; Henricus F M van der Heijden; Lioe-Fee de Geus-Oei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-10       Impact factor: 9.236

2.  Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer.

Authors:  Wenfeng Yang; Yongming Zhang; Zheng Fu; Jinming Yu; Xiaorong Sun; Dianbin Mu; Anqin Han
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-23       Impact factor: 9.236

3.  Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.

Authors:  Sheng-Chieh Chan; Shu-Hang Ng; Joseph Tung-Chieh Chang; Chien-Yu Lin; Yen-Chao Chen; Yu-Chen Chang; Cheng-Lung Hsu; Hung-Ming Wang; Chun-Ta Liao; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-19       Impact factor: 9.236

4.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Authors:  Ronald Boellaard; Wim J G Oyen; Corneline J Hoekstra; Otto S Hoekstra; Eric P Visser; Antoon T Willemsen; Bertjan Arends; Fred J Verzijlbergen; Josee Zijlstra; Anne M Paans; Emile F I Comans; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

5.  Imaging proliferation of ¹⁸F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer.

Authors:  Wenfeng Yang; Yongming Zhang; Zheng Fu; Xiaorong Sun; Dianbin Mu; Jinming Yu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05-12       Impact factor: 9.236

6.  Scanning linear estimation: improvements over region of interest (ROI) methods.

Authors:  Meredith K Kupinski; Eric W Clarkson; Harrison H Barrett
Journal:  Phys Med Biol       Date:  2013-02-06       Impact factor: 3.609

7.  18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off.

Authors:  Johannes Salamon; Simon Veldhoen; Ivayla Apostolova; Peter Bannas; Jin Yamamura; Jochen Herrmann; Reinhard E Friedrich; Gerhard Adam; Victor F Mautner; Thorsten Derlin
Journal:  Eur Radiol       Date:  2013-10-05       Impact factor: 5.315

8.  A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data.

Authors:  Andrea Schaefer; Stephanie Kremp; Dirk Hellwig; Christian Rübe; Carl-Martin Kirsch; Ursula Nestle
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-26       Impact factor: 9.236

9.  Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?

Authors:  L Tessonnier; F Sebag; F F Palazzo; C Colavolpe; C De Micco; J Mancini; B Conte-Devolx; J F Henry; O Mundler; D Taïeb
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-20       Impact factor: 9.236

10.  18F-FDG PET/CT in the diagnosis of prosthetic valve endocarditis.

Authors:  Erika Fagman; Martijn van Essen; Johan Fredén Lindqvist; Ulrika Snygg-Martin; Odd Bech-Hanssen; Gunnar Svensson
Journal:  Int J Cardiovasc Imaging       Date:  2015-11-26       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.